Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Associate

Gaby Boria

Goodwin Procter

main

Boria Gaby

Goodwin Associate Gaby Boria, from New York, practices in the Business Law Department with an emphasis on life sciences.

Gaby Boria

Areas of Practice

Credentials

Education

JD

BA

Admissions

Bars

Related Content

Goodwin Advises Intellia Therapeutics on $194.6 Million Pricing of Public Offering of Common Stock

The Chemours Company Completes Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034

Goodwin Represents the Initial Purchasers on WhiteFiber’s Upsized $230 Million 4.50% Convertible Senior Notes Offering

Bitdeer Completes $400 Million Convertible Senior Notes Offering with Capped Call and Registered Direct Offering

Goodwin Represents the Initial Purchasers and Dealers on Ligand’s Upsized $460 Million 0.75% Convertible Senior Notes and Call Spread

BlackSky Closes Upsized $185 Million Convertible Notes Offering

Life Sciences